JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M105512200 on November 6, 2001

J. Biol. Chem., Vol. 277, Issue 5, 3158-3167, February 1, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/5/3158    most recent
M105512200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reguera, R. M.
Right arrow Articles by Ordóñez, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reguera, R. M.
Right arrow Articles by Ordóñez, D.

Cloning Expression and Characterization of Methionine Adenosyltransferase in Leishmania infantum Promastigotes*

Rosa M. RegueraDagger §, Rafael Balaña-FouceDagger , Yolanda Pérez-PertejoDagger , Francisco J. Fernández, Carlos García-EstradaDagger , Juan C. CubríaDagger , César OrdóñezDagger , and David OrdóñezDagger §

From the Dagger  Departamento de Farmacología y Toxicología, Facultad de Veterinaria, Universidad de León Campus de Vegazana s/n, 24071 León, Spain and the  Dpto. de Biotecnología, Ciencias Biológicas y de la Salud Universidad Autonóma Metropolitana-Iztapalapa Avda. de Michoacán y la Purísima, s/n Colonia Vicentina, Iztapalapa 09340, México D.F.

Received for publication, June 14, 2001, and in revised form, October 29, 2001


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Methionine adenosyltransferase (MAT) catalyzes the synthesis of s-adenosylmethionine (AdoMet), a metabolite that plays an important role in a variety of cellular functions, such as methylation, sulfuration, and polyamine synthesis. In this study, genomic DNA from the protozoan parasite Leishmania infantum was cloned and characterized. L. infantum MAT, unlike mammalian MAT, is codified by two identical genes in a tandem arrangement and is only weakly regulated by AdoMet. L. infantum MAT mRNA is expressed as a single transcript, with the enzyme forming a homodimer with tripolyphosphatase in addition to MAT activity. Expression of L. infantum MAT in Escherichia coli proves that the MAT and tripolyphosphatase activities are functional in vivo. MAT shows sigmoidal behavior and is weakly inhibited by AdoMet, whereas tripolyphosphatase activity has sigmoidal behavior and is strongly activated by AdoMet. Plasmids containing the regions flanking MAT2 were fused immediately upstream and downstream of the luciferase-coding region and transfected into L. infantum. Subsequent examination of luciferase activity showed that homologous expression in L. infantum promastigotes was dramatically dependent on the presence of polypyrimidine tracts and a spliced leader junction site upstream of the luciferase gene, whereas downstream sequences appeared to have no bearing on expression.


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Methionine adenosyltransferase (MAT1; S-adenosyl-L-methionine synthetase, EC 2.5.1.6) catalyzes the synthesis of S-adenosylmethionine (AdoMet) from L-methionine and ATP (1, 2) in all living organisms. AdoMet is a critical metabolite in transmethylation and transulfuration reactions and a precursor in polyamine metabolism. AdoMet is the major donor of methyl groups for transmethylation reactions in eukaryotic systems (3, 4). S-Adenosylhomocysteine (AdoHcy), generated by the transfer of a methyl group from AdoMet, is converted to adenosine and homocysteine by AdoHcy hydrolase (5). Because cells try to maintain low AdoHcy levels, the AdoMet/AdoHcy ratio is indicative of the relative potential for transmethylation reactions, once the S-methyl moiety has been transferred and the AdoHcy is cleaved by AdoHcy hydrolase (6). Homocysteine can be readily transformed into cysteine, thereby participating in the metabolism of glutathione, the scavenger tripeptide involved in the sulfur redox status of eukaryotes (7). Finally, 2-5% of total intracellular AdoMet is used as a precursor for higher polyamines such as spermidine and spermine in all living cells (8). After AdoMet is decarboxylated, the released aminopropyl moiety can be captured by putrescine and spermidine to synthesize spermidine and spermine, respectively (9).

MAT enzymes are involved in two enzymatic activities. In the first reaction AdoMet and tripolyphosphate (PPPi) are synthesized from ATP and L-methionine. In the second, the tripolyphosphate is hydrolyzed to orthophosphate (Pi) and pyrophosphate (PPi) before the products are released. MAT-I and MAT-III, products of the same MAT1A gene, are predominantly expressed in adult liver (10). MAT-II, a product of the MAT2A gene, is present in most tissues of the fetus and newborn, and in the kidney, brain, lymphocytes, testis, lens, as well as the early regenerating liver of adults (11, 12). The tetramer MAT-I (Mr 200,000) and dimer MAT-III (Mr 100,000) are oligomeric forms of the alpha 1 subunit (13), whereas MAT-II (Mr 185,000) is a heterooligomeric complex comprised of alpha 2/alpha 2' (11) and beta  subunits (14). The alpha 2' subunit of the MAT-II isozyme is considered to be a post-translational modification of the alpha 2 subunit that occurs as the organism matures.

There are few reports on AdoMet metabolism in Trypanosomatids. Yarlett et al. (15) described two different MAT isoforms in Trypanosoma brucei, which were evident from Eadie-Hofstee and Hanes-Woolf plots, that had different affinities for L-methionine and ATP. The depletion of polyamine metabolism with the irreversible enzyme-activated inhibitor of ornithine decarboxylase, alpha -DL-difluoromethylornithine (DFMO), caused massive accumulation of AdoMet and decarboxylated AdoMet (dcAdoMet) in trypanosomes. The reason for this buildup is due to the unregulated nature of the trypanosome MAT (16). In mammalian tissues this enzyme is closely regulated by its product, whereas the MAT activity in trypanosomes is not. After DFMO treatment and increases in AdoMet concentration, the methylation index (the ratio of AdoMet to AdoHcy) in trypanosomes raises to >100, whereas in mammalian cells this ratio is on the order of 5-10 (17). This striking difference between host and parasite may be the grounds for establishing MAT as a drug target in polyamine-based chemotherapy (3).

In this report we describe the cloning and organization of the MAT2 gene from Leishmania infantum, as well as the heterologous expression, protein purification, and kinetic analysis of the recombinant enzyme.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Cell Culture-- L. infantum LEM 75 zymodeme 1 was a generous gift from Dr. Requena (Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas Madrid). The cells were grown as promastigotes (flagellated, insect form) in Schneider's insect medium (Sigma Chemical Co., St. Louis, MO), supplemented with 10% heat-inactivated fetal calf serum (Roche Molecular Biochemicals, Germany), penicillin (50 units/ml), and streptomycin (50 µg/ml).

Nucleic Acid Isolation-- Genomic DNA from L. infantum promastigotes was isolated from 2.0 × 109 cells in 10 mM EDTA, 150 mM NaCl, 0.4% SDS, and 50 µg/ml proteinase K and incubated at 65 °C for 1 h followed by 37 °C overnight incubation. DNA was further purified by phenol and phenol/chloroform extraction and ethanol precipitation. Qiagen columns were used for RNA isolation following the manufacturer's instructions.

Isolation of an L. infantum MAT2 Fragment by PCR-- To generate a DNA probe for isolation of the L. infantum MAT2 gene, PCR was employed using degenerated oligonucleotides based on conserved amino acid sequences in mouse (18), rat liver (19), human liver (20), Saccharomyces cerevisiae (21, 22), and Escherichia coli (23) MAT proteins. A sense primer, 5'-GAG GGC CA(C/T) CC(C/G) GA(C/T) AAG-3', was designed encoding EGHPDK amino acid residues. The antisense primer 5'-(C/G)GG GCC GCC (G/A)AT (G/C)AC GAA-3' was designed for amino acid residues PGGIVF. 500 ng of L. infantum genomic DNA was added to a reaction mixture containing 50 mM KCl, 10 mM Tris-HCl, pH 9.0, 1% Triton X-100, 2.5 mM MgCl, 200 µM of each deoxynucleotide triphosphate, 50 pmol of each oligonucleotide primer, and 2.5 units of Taq DNA polymerase in a final volume of 50 µl. A 636-bp product was generated after 30 cycles of denaturation at 94 °C for 1 min, annealing at 50 °C for 2 min, and extension at 72 °C for 1 min. PCR products were isolated from 2% low melting point agarose gels, and the purified DNA fragments were ligated to pGEM-T vector (Promega) and transformed into a competent E. coli, DH5alpha strain. Plasmids were isolated on Wizard columns (Promega), according to the manufacturer's recommendations. The amplified product was sequenced on both strands using the dideoxy chain termination method (24) with fluorescent primers and T7 polymerase. Sequencing was performed in an ALF automated sequencer (Amersham Biosciences, Inc.) placed at the core facility of Universidad de León.

Isolation of the L. infantum MAT2 Gene-- The EMBL L. infantum library (25) was kindly supplied by Dr. Requena (Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas, Madrid). A total of 50,000 bacteriophages was blotted onto positively charged nylon membranes (Amersham Biosciences, Inc.) and prehybridized for 4 h at 42 °C in 5× Denhardt's solution, 5× SSC, 50 mM sodium phosphate, pH 6.5, 100 µg/ml salmon sperm DNA, and 50% formamide for screening with DNA probes. The membranes were hybridized for 16-20 h at 42 °C in the same buffer containing 106-107 cpm of the 636-PCR product radiolabeled with [alpha -32P]dCTP (Amersham Biosciences, Inc.), using the random primer method. Filters were washed twice with 2× SSC plus 0.1% SDS at 42 °C for 10 min each, followed by two washes in 1× SSC, plus 0.1% SDS at 42 °C for 10 min. Positive bacteriophages were subjected to a second and third purification, and DNA was isolated from amplified phages using the liquid culture method as described by Sambrook et al. (26).

Subcloning and Sequencing of the L. infantum MAT2 Gene-- The isolated bacteriophage DNA was digested with restriction endonucleases, electrophoresed on 0.7% agarose gels, and transferred by Southern's method (27) to positively charged nylon membranes. Southern blots were probed with the 636-bp PCR product under the conditions described above for screening the genomic library. The 3.2- and 1.8-kb PstI-fragments that hybridized to the probe were ligated into pGEM-3Zf(+) and transformed into E. coli, DH5alpha strain. Large scale preparation of the pGEM-3Zf(+) plasmid containing the 3.2- and 1.8-kb PstI fragments was done using Qiagen columns, and the inserts were sequenced as mentioned above. Analyses of nucleotide and amino acid sequences were performed using the BLAST algorithm from the National Center for Biotechnology Information database.

Southern and Northern Hybridizations-- Genomic DNA from L. infantum was digested with the appropriate restriction enzymes under the conditions recommended by the suppliers. Digested DNA was electrophoresed on 0.7% agarose gels and transferred to positively charged nylon membranes as described above. For identification of specific MAT2 transcripts, total RNA was electrophoresed on 1.2% agarose (formaldehyde gels) and transferred to positively charged nylon membranes.

Mapping the 5'-End Using RT-PCR-- To amplify the 5'-end of MAT2, total RNA was used as a template for RT-PCR. Reverse transcription steps were performed with avian myeloblastosis virus-reverse transcriptase (Promega) following the manufacturer's protocol (10 µg of total RNA/reaction). PCR was performed using Taq polymerase (Amersham Biosciences, Inc.) with 30 cycles of denaturation at 95 °C for 30 s, annealing at 55 °C for 2 min, and extension at 72 °C for 2 min. The primers used for RT were: 5'-TCG GGA TCC CAA CGC TAT ATA AGT ATC AGT TTC TGT ACT TTA TTG-3', a sense primer containing the sequence that codifies the spliced leader region, and 5'-CTT GTC TGG ATG GCC CTC CGT-3', an antisense primer located at the end of the MAT2 gene.

Cloning and Expression of the MAT2 Gene-- The genomic DNA prepared from L. infantum cultures was amplified by PCR using the proofreading DNA polymerase Pfu (Stratagene) with the following specific primers, 5' sense primer, 5'-CGGGATCCATGTCTGTCCACAGCATTCTCTTC-3', and the 3' antisense primer, 5'-AACTGCAGTTACTCGACCATCTTCTTTGGCAC-3'. A BamHI restriction site was created upstream of the initiation ATG codon in the sense primer, and a PstI restriction site was introduced into the antisense primer downstream of the termination codon. Subcloning of this product into the pQE-30 (Qiagen) expression vector yields pQE30-MAT2. Competent E. coli, JM109 cells were transformed with pQE30-MAT2. Transformed bacterial clones were grown at 37 °C in LB medium containing 100 µg ml-1 ampicillin to an absorbance at 600 nm (A600) of 0.5 unit. Protein expression was induced by adding isopropyl-beta -D-thiogalactopyranoside to a final concentration of 0.5 mM. The cells were grown for an additional 3 h at 37 °C, and then separated by centrifugation (8000 × g for 15 min) at 4 °C. The pellets were resuspended in ice-cold phosphate-buffered saline (PBS) solution, washed three times in PBS, and stored at -80 °C until use.

Purification of Recombinant MAT-II-- The protein was partially purified using the method described by Lopez-Vara et al. (28). The bacterial pellet was resuspended in water at 0 °C for 10 min to facilitate cell wall lysis and centrifuged at 8000 × g for 10 min. The pellet was resuspended in 10 ml of solution A: 50 mM Tris-HCl, pH 8.0, 10 mM DTT, 10 mM MgSO4, and protease inhibitors (2 µg/ml aprotinin, 1 µg/ml pepstatin A, 0.5 µg/ml leupeptin, 2.5 µg/ml antipain, 0.1 mM benzamidine, and 0.1 M phenylmethylsulfonyl fluoride). Cell extracts were prepared by sonication with ten 30-s pulses at 50 watts and 30-s intervals with a U50-control sonicator (Kika Labortechnick). Soluble and insoluble fractions (including inclusion bodies) were separated by centrifugation for 15 min at 10,000 × g. Pellets from the insoluble fraction were resuspended in 10 ml of buffer A. Nucleic acids were digested by incubating the cell debris with 40 µg ml-1 DNase I and 130 units ml-1 T1 RNase at room temperature for 20 min. The inclusion bodies were diluted in solution A (w/v 1:4), centrifuged at 10,000 × g for 10 min, and washed three times by resuspension in 10 ml of solution A supplemented with 5% Triton X-100 and 4 M urea and collected by centrifugation at 4 °C (10,000 × g for 10 min). A final wash with the same buffer without urea and Triton X-100 was performed. The washed pellet was solubilized in 10 ml of solution B (50 mM Tris-HCl, pH 8.0, 10 mM MgSO4), supplemented with 8 M urea, and subjected to mild agitation for 2 h at 10 °C. Protein refolding was achieved by a 20-fold dilution (protein concentration: 0.3-18 mg/ml) in solution B containing 2 M urea. The suspension was left overnight at 4 °C under gentle agitation and centrifuged at 13 000 × g for 30 min, after which the pellet was discarded. The resulting supernatant was dialyzed three times for 4 h each against buffer C (50 mM Tris-HCl, pH 8.0, 10 mM MgSO4, and 10 mM DTT) at 4 °C to remove the urea. Dialyzed samples were clarified by centrifugation at 10,000 × g for 30 min before any determination was carried out.

Purification by Nickel-Agarose Bead Affinity Capture-- The recombinant MAT-II protein was purified from inclusion bodies by affinity on nickel-agarose beads (Qiagen). In a 15-ml tube, 2 ml of the 50% nickel-agarose slurry was spun down at 1000 × g for 2 min, and then the pellet was equilibrated with a buffer containing 300 mM NaCl, 50 mM sodium phosphate, pH 8.0, and 8 M urea. Inclusion bodies resuspended in solution B, supplemented with 8 M urea (containing about 10 mg of total proteins) were added and incubated for 30 min at 4 °C with gentle mixing. The equilibrated gel was poured into the column and allowed to settle. The column was washed several times with 5 ml of equilibrated buffer until the absorbance at 280 nm of the flow-through material was undetectable. Bound proteins were eluted with 10 ml of 300 mM imidazole and dialyzed against 50 mM Tris-HCl, 10 mM MgSO4, and 10 mM DTT as described above.

Generation of MAT-II Antisera-- Polyclonal antisera against L. infantum MAT-II was generated by inoculating the purified protein in New Zealand White male rabbits (Criffa, Barcelona, Spain). Preimmune blood was drawn prior to the initial immunizations, and the sera were used as a negative control. The recombinant protein was combined and emulsified in an equal volume of Freund's complete adjuvant (Sigma Chemical Co.) and injected into the rabbits. The initial injections were made in three sites: each hindquarter and the back of the neck. Boosters were made every 2 weeks following the removal of 10 ml of blood from the ear vein to test the immune response. The final rabbit serum was collected after the titers had reached a plateau (12-14 weeks). Antisera titers were assessed by immunoblotting after preparation of L. infantum crude extracts on a reducing 15% SDS slab gel and transfer to a nylon membrane.

SDS-PAGE and Western Blotting-- L. infantum promastigotes were harvested at different times during the growth and washed twice with PBS. After sonication and centrifugation at 10,000 × g for 20 min, the supernatant was removed. 50 µg of protein from each time point were diluted in loading buffer (60 mM Tris-HCl, pH 6.8, 2% SDS, 5% 2-mercaptoethanol, and 5% glycerol), heated in a boiling water bath for 5 min, and analyzed by SDS-PAGE (10% acrylamide, 2.7% bisacrylamide). Proteins were electrotransferred onto nylon membranes for 1 h at 25-30 V/cm, and the blots were blocked by incubation in 10 mM Tris-HCl, pH 7.5, 1 M NaCl, 0.5% Tween 20, 5% nonfat milk powder (w/v) for 1 h at room temperature. Primary antibody was added to this buffer, and the blot was incubated for 2 h. The blot was washed thoroughly in 10 mM Tris-HCl, pH 7.5, 1 M NaCl, 0.5% Tween 20 and then incubated with an anti-rabbit antibody conjugated to alkaline phosphatase. Antibodies were detected using nitro blue tetrazolium chloride as substrate (Roche Molecular Biochemicals).

MAT Assay-- MAT activity was assayed as described previously (29). The assay included, in a total volume of 250 µl, 5 mM L-methionine, 1 mM ATP (containing [2,8-3H]adenosine 5'-triphosphate, 46 Ci/mmol, Amersham Biosciences, Inc.) in 100 mM Tris-HCl, pH 8.0, 240 mM KCl, 12 mM MgCl2, and 10 mM DTT. The reaction was stopped with 4 ml of ice-cold water. Reaction mixtures were loaded onto AG 50W-X4 cationic exchanger columns, washed twice with 10 ml water, and eluted with 4 ml of M NH4OH. Samples were measured in a scintillation counter using 10 ml of an Optiphase-Hisafe 3 (Wallac) mixture for aqueous mixtures. One unit of MAT activity is defined as the amount of enzyme that catalyzes the formation of 1 nmol of AdoMet per hour and per mg of protein. Protein was determined using the Bradford method (30). Each data point was measured by triplicate and presented as the mean. The kinetic parameters for L-methionine and ATP were calculated under steady-state conditions. Kinetic constants for L-amino acid were determined in the presence of 0.05 to 5 mM ATP and 0.025 to 2.5 mM L-methionine, whereas nucleoside constants were ascertained in the presence of 0.05 to 1 mM L-methionine and 0.05-5 mM ATP.

Native Molecular Weight Determination-- Gel-filtration chromatography was used to determine both native and recombinant L. infantum MAT-II molecular weight. 2 ml of freshly prepared recombinant MAT-II was loaded onto a Sephacryl S-300 column (75 × 1.5 cm) (Amersham Biosciences, Inc.), equilibrated with 50 mM Tris-HCl, pH 8.0, 10 mM MgSO4, and 10 mM DTT. Chromatography was performed at 4 °C and a flow rate of 10 ml/h with the same elution buffer, containing protease inhibitors, and 2.5-ml fractions were collected. The column was previously calibrated with S-300 molecular weight markers; chymotrypsinogen A (23,000), ovoalbumin (43,000), bovine serum albumin (67,000), and aldolase (158,000) (Sigma), whose A280 profile for standards were spectrophotometrically determined. The eluted fractions were used to assay either for MAT activity, with the method described above, or for immunoblotted detection against the MAT-II antibody.

One liter of promastigotes were grown as described previously for gel filtration analysis of native MAT-II. The cells were harvested after 3 days and washed twice by centrifugation in PBS. Pellet was resuspended in 2 ml of 50 mM Tris-HCl, pH 8.0, 10 mM MgSO4, and 10 mM DTT in the presence of protease inhibitors, and disrupted by sonication. The cytosolic fraction, obtained after centrifugation for 60 min at 100,000 × g at 4 °C, was loaded onto the same column and eluted under similar conditions.

L. infantum Promastigotes Transient Transfections-- Cells were grown in Schneider's insect medium until the log late phase was reached. 4 × 107 cells were electroporated with 10 µg of DNA, 20 µg of sheared salmon sperm DNA as carrier, and 2 µg of pX63NEO-beta gal plasmid as control for transfection efficiency. Transfections were performed in a Gene Pulser II unit (Bio-Rad) using 2250 V/cm and a capacitance of 500 microfarads. Following electroporation, cells were inoculated into 10 ml of Schneider's insect medium and grown for 20 h at 26.5 °C (31).

Plasmid Constructions-- Three fragments of different lengths belonging to the upstream region of the MAT2 gene were generated by PCR, using an MAT2 genomic clone as template. The resulting fragments were 415-, 355-, and 136-bp long and contained new BamHI and NotI restrictions sites at the ends. The sense primers for the fragments extended from -415 to -398, from -355 to -336, and from -136 to -116, respectively. The antisense primer was the same for all fragments and extended from position -21 to -1. After cleavage with BamHI and NotI, these fragments were cloned into the BamHI and NotI sites just upstream of the luciferase coding region in the promoterless pGEM-luc vector (Promega). The identity of the constructions was confirmed by sequencing. At the same time, another fragment, containing the 3'-UTR and IR between both MAT2 genes, was amplified by PCR with specific primers containing SacI restriction sites. After cleavage, it was cloned into SacI site, located downstream of the luciferase coding region in the promoterless pGEM-luc vector. Insert orientation was confirmed by sequencing.

Luciferase and Galactosidase Assays-- Cells were collected by centrifugation, resuspended in 1.4 ml of Hanks' balanced salt solution, and pelleted. The pellets were suspended in 160 µl of 50 mM Tris-HCl, pH 7.5, containing protease inhibitors (TPI buffer). The cells were lysed by sonication and centrifuged at 4 °C for 15 min. 80 µl of the supernatant was assayed for luciferase activity using the Luciferase Assay System (Promega). Luminescence was measured in a Labsystems Luminoskan luminometer. The rest of the supernatant (80 µl) was assayed for beta -galactosidase activity to adjust the transfection efficiency by adding 320 µl of assay buffer (23 mM Tris-HCl, pH 7.5, 125 mM NaCl, 2 mM MgCl2, 12 mM beta -mercaptoethanol) and 0.3 mM 4-methyl-umbelliferyl beta -D-galactoside (Sigma). After incubation for 5 h at 37 °C, the reaction was stopped by adding 2 ml of 133 mM glycine/83 mM Na2CO3, pH 10.7 (32). 4-Methylumbelliferone fluorescence was measured in a spectrofluorometer (Hitachi F2500). Luciferase activity values were adjusted to the beta -galactosidase activity results to verify transfection efficiency, taking the pX63NEO-luc-transfected cells values as 100%. The results are shown as the mean ± S.D. from five independent measurements.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Molecular Cloning and Sequencing of the L. infantum MAT2 Gene-- The cloning strategy employed was based on the design of degenerate primers representing conserved internal protein sequences from phylogenetically unrelated organisms (20-25) and PCR amplification using purified L. infantum DNA as template. A 636-bp PCR product that encodes a portion of internal Leishmania MAT2 gene was amplified from genomic DNA and used as a probe to isolate the entire genomic locus. The suitability of this 636-bp PCR fragment was initially evaluated by sequencing and comparison to the NCBI sequence database (Basic Blast) (33). 50,000 bacteriophages from a Lambda-EMBL3 Leishmania library were screened with the random primer-labeled 636-bp PCR probe as described under "Experimental Procedures." One positive plaque was identified and isolated. This clone contained ~20 kb of Leishmania DNA. More than one band was identified with this probe in Southern blot analysis of bacteriophage DNA digested with restriction endonucleases (Fig. 1A).


View larger version (57K):
[in this window]
[in a new window]
 
Fig. 1.   Southern blot analysis of MAT2 locus in L. infantum. A, bacteriophage DNA (2 µg) containing L. infantum MAT2 was digested with the restriction endonucleases indicated (ApaI, EcoRV, HindIII, PstI, SacII, SalI, SmaI, and XhoI) or combined with EcoRI to excise the bacteriophage arms and subjected to Southern blot analysis using the 636-bp PCR probe. The three faint bands (approximately 2.0 kb) located between the PstI-SacII and SalI-SmaI lanes correspond to a band hybridizing with the molecular weight markers. The 3.2- and 1.8-kb fragments obtained by PstI digestion were used for cloning and are indicated with an asterisk. B, Southern blot analysis of the wild type MAT2 loci. Genomic DNA (20 µg) was isolated from L. infantum promastigotes, digested with ApaI, EcoRV, KpnI, NcoI, SalI, XhoI, BamHI, EcoRI, and HindIII, resolved on a 0.7% agarose gel, and blotted onto nylon membranes. Blots were hybridized to a 636-bp PCR fragment under high stringency conditions. The KpnI lane did not show any hybridization band due to sample degradation.

Two fragments, 3.2 and 1.8 kb from the isolated bacteriophage obtained by PstI digestion (marked in Fig. 1A with an asterisk), were chosen for subcloning into pGEM-3Zf(+) and completely sequenced on both strands. Sequence analysis identified the presence of two identical 1179-nucleotide ORFs, which could each be expected to encode a protein consisting of 394 amino acids with an estimated molecular mass of 43 kDa. We have termed these ORFs MAT2 (see GenBankTM accession number AF031902). In addition to the MAT2 coding region, the 3.2-kb fragment contained 421 bp upstream of the initial MAT2 codon and ~2 kb downstream of the stop codon. In these genes, which have no introns (confirmed by lambda -gt11 cDNA L. infantum library screening), G + C accounted for 62% of the overall base composition. Multiple sequence alignment (Fig. 2) of the L. infantum MAT-II protein with other proteins from phylogenetically diverse organisms, revealed that MAT-II contained all the sequence motifs related to ATP binding (the nonapeptide GGGAFSGKD (34)), metal binding (Asp-19, Asp-282, and Glu-45 (35)), and the MAT active site (GAGDQG at position 118-123) found in mammalian, yeast, Plasmodium falciparum, and E. coli MAT isozymes.


View larger version (80K):
[in this window]
[in a new window]
 
Fig. 2.   Multiple amino acid sequence alignments of L. infantum MAT-II. The predicted amino acid sequences predicted for the L. infantum, P. falciparum, E. coli, S. cerevisiae, human liver, and human kidney MAT were aligned using the ClustalX multiple sequence alignment program. Symbols: "*" represents identical or conserved residues in all sequences in the alignment, ":" conserved substitutions and "." semi-conserved substitutions. Complete genomic sequences of MAT proteins are available in GenBankTM, for L. infantum accession number (AF031902), P. falciparum (AF097923), E. coli (K02129), S. cerevisiae (M23368), human liver (X69078), and human kidney (X68836).

Genomic Organization of the MAT2 Locus-- To determine the number and organization of MAT2 genes in L. infantum genome, a Southern blot analysis was performed. Several enzymes whose cleavage sites are not present in the MAT2 coding region were used to digest DNA, and blots were probed with the 636-bp PCR-labeled product. Complete digestion resulted in two copies in the L. infantum genome, because ApaI, EcoRV, SalI, and XhoI (which do not cut inside the MAT2 coding region), each excised two hybridizing bands of unequal size (Fig. 1B).

These two copies may be organized either head to head or head to tail as Fig. 3A shows. We designed oligonucleotides based on the sequences inferred from 3.2- and 1.8-kb fragments (see Fig. 1A) to obtain a more detailed picture on the genomic organization of this gene and determine the intergenic region (IR). The oligonucleotides were designed to be able to amplify the region between these genes via PCR. Primer 1, 5'-CCAAAGAAGATGGTCGAC-3', is a sense primer whose sequence corresponded to the 3'-end coding region; primer 2, 5'-AATGCTGTGGACAGACAT-3', is an antisense primer with a sequence corresponding to the 5'-end of the coding region; and primer 3, 5'-GACTGACCGGCTTTCTAG-3', is also an antisense primer corresponding to the 3'-end of the coding region. After PCR amplification under the conditions described under "Experimental Procedures," in which genomic L. infantum DNA was used as a template, a single 4-kb band was originated with primers 1 and 2, whereas with primers 1 and 3 no fragments were amplified (Fig. 3B, lanes 2 and 3). The 4-kb band was subcloned into pGEM-3Zf(+) and sequenced on both strands, in which the sequence of the last 421 bp was identical to the sequence found upstream of the MAT2 gene in the 3.2-kb fragment (Fig. 3D). To ascertain whether this homology extends beyond the 421-bp fragment, bacteriophage DNA isolated from the L. infantum EMBL3 genomic library was digested with KpnI, an enzyme that cleaves the region between both copies of MAT2 gene at a single site, generating two fragments, with 5.5 and 4.5 kb, respectively, both hybridizing with the 636-bp PCR probe (Fig. 3C). The two fragments were separated in low melting point agarose gels and subcloned into pGEM-3Zf(+) for sequencing. Sequence analysis showed that they contained the MAT2 gene, included in the previously isolated 3.2-kb fragment, as well as a second 2.0-kb fragment located upstream of the ATG codon. This 2.0-kb piece was identical to the sequence found at the end of the 4-kb IR and contained an ORF located upstream of both MAT2 genes. These ORFs showed a 37% amino acid homology with an unknown protein named L2259.4 (see GenBankTM accession number AC009602), ascertained by PSORT algorithm analysis to be located in the nucleus.


View larger version (49K):
[in this window]
[in a new window]
 
Fig. 3.   Organization of MAT2 gene copies. A, schematic representation showing possible organization of MAT2 gene copies (gray boxes) in the L. infantum genome; the small arrows indicate the position of the primers used in the amplification of the intergenic region. B, agarose gel showing the PCR product obtained under the conditions described under "Experimental Procedures" and the negative control. C, bacteriophage DNA digested with KpnI and Southern blot analysis with the 636-bp PCR fragment. D, schematic representation showing the L. infantum MAT2 locus. Gray boxes symbolize MAT2 gene copies separated by a 4-kb IR, white boxes represent an ORF found upstream of both MAT2 gene copies, dotted boxes indicate the 2.0-kb conserved fragment located upstream of each MAT2 genes, and stripped boxes contain the spliced leader junction site. A thick black line indicates the location of the probe. Capital letters denote several restriction sites: EcoRV (E), KpnI (K), PstI (P), SmaI (S), and XhoI (X).

Attempts were also made to identify the location of the spliced leader junction site. The 5'-end of the mature mRNAs was mapped with reverse transcriptase, and PCR was carried out as described under "Experimental Procedures." Electrophoresis of the PCR products on agarose gels yielded only one 120-bp product. Nucleotide sequence analysis demonstrated that the MAT2 transcript spliced leader junction site was located at nucleotide -42 (boldface AG dinucleotide in Fig. 4) from the predicted translation initiation site.


View larger version (37K):
[in this window]
[in a new window]
 
Fig. 4.   RT-PCR mapping of the 5'-UTR of the MAT2 transcript. A, ethidium bromide stained agarose gel of the RT-PCR product. Total RNA was amplified using nondegenerate primers as described under "Experimental Procedures." The spliced leader sequence was used as the sense primer, and as antisense primer, an internal gene sequence was used. Lane 1 shows the amplified product, whereas lane 2 exhibits the negative control, in which no antisense primer was used. B, 421 nucleotides located upstream of the ATG codon, containing the polypyrimidine tracts (underlined) and the spliced leader junction site (boldface AG dinucleotide) predicted by mapping of the 5' terminus of the MAT2 transcript.

Expression of the MAT2 Genes-- Total RNA was isolated from promastigotes at various times during culture growth and probed in Northern blots with MAT2 coding region (Fig. 5A). Promastigotes in these cultures entered the logarithmic phase of growth 1-2 days after passage and reached the stationary phase by day 5. Fig. 5B shows a single 2.5-kb RNA species that appears to show constitutive expression during the experimental interval, whereas panel A shows variations in RNA loading. In this particular experiment more RNA was added to lane 4 and less to lanes 5 and 6. When differences in gel loading are taken into account, the increases in late logarithmic phase MAT2 RNA production are not consistent with the relative band intensities in panel A. Antibodies against MAT-II fusion protein were used to determine polypeptide expression at different stages of culture growth. Panel C shows the expression of the MAT-II protein in L. infantum. Only one 49-kDa peptide was detected on any of the growth days tested, and the relative intensity of the band was the same throughout the experiment.


View larger version (43K):
[in this window]
[in a new window]
 
Fig. 5.   Northern blots showing MAT2 mRNA abundance during promastigote culture growth. A, ethidium bromide staining. Total RNA was isolated from cultured promastigotes in the logarithmic (days 2-3), late logarithmic-early stationary (days 4-5), and stationary (day 6) phases. RNAs (20 µg per lane) were loaded onto agarose gel-formaldehyde, separated by electrophoresis, and transferred to a nylon membrane. B, the membrane was probed with the MAT2 gene coding region. The arrow indicates the 2.5-kb transcript. C, Western blot analysis using polyclonal antiserum raised against His6-MAT-II. Cells were harvested at different growth times, proteins were extracted, and 50 µg of L. infantum whole cell lysate was applied to a 10% SDS-PAGE. Only one 49-kDa immunoreactive band was detected in L. infantum promastigotes.

Functional Analysis of Recombinant MAT-II and Molecular Weight Determination-- The expression of the L. infantum MAT-II recombinant protein in E. coli JM109 resulted in an abundant protein with an Mr of ~49,000 (Fig. 6A, lanes 7-9). Analysis of the soluble and insoluble fractions of the bacterial culture at different induction times indicated that the expression product was concentrated in the insoluble inclusion bodies. MAT-II recombinant protein was expressed as an His6-tag fusion for more efficient nickel-agarose resin purification. The MAT-II recombinant protein obtained with this method was used to produce specific antiserum. The enzyme activity of the preparation was very low, however. An alternative method for enzyme purification and activation, based on a previous study (28), was highly successful. Triton X-100 and 8 M urea-buffered extraction of the inclusion body phase resulted in a significant increase in purity (Fig. 6B, lane 3). After equilibrium dialysis against 50 mM Tris-HCl, pH 8.0, containing 10 mM MgSO4 and 10 mM DTT, extracts were active and contained over 99% of the MAT protein. MAT activity was linear in terms of both time (up to 90 min) and protein concentration (data not shown). The steady-state activity at saturation of both substrates, i.e. 5 mM ATP and 5 mM L-methionine, was 12 µmol/mg/h (kcat = 0.32 s-1). The enzyme exhibited slightly sigmoidal behavior with both L-methionine and ATP. Fig. 7A shows that there is positive cooperativity between MAT and L-methionine at different ATP concentrations. Cooperativity, estimated to be n = 2.3 (ATP = 0.5 mM) declined with increasing ATP levels to close 1 (ATP = 5 mM). The K' values for L-methionine were not significantly affected by ATP and were estimated to be 250 ± 25 µM. Conversely, when assessed as a function of ATP at different L-methionine levels (Fig. 7B), MAT activity was sigmoidal (n = 1.8). The K' values for ATP were estimated to be 370 ± 80 µM, with the sigmoidal shape of the curve persisting at rising concentrations of the L-amino acid. The tripolyphosphatase activity of L. infantum recombinant MAT-II was measured under the standard assay conditions described under "Experimental Procedures." Tripolyphosphatase activity (Fig. 8A) was linear in terms of time and protein concentration, and no Pi was released in the absence of recombinant MAT-II. Under steady-state conditions, behavior was found to be sigmoidal, showing a kcat of 0.04 s-1 and a K' value of 30 µM. The kcat values determined at saturating concentrations of tripolyphosphate, ATP, and L-methionine showed that the rate of AdoMet synthesis is higher than the rate of tripolyphosphate cleavage. Because the final process should be dependent on the slowest reaction, tripolyphosphatase activity might be responsible for the AdoMet synthesis rate in Leishmania. However, tripolyphosphate affinity and the presence of the AdoMet synthesized in the first step of the reaction, in the active site, stimulate tripolyphosphatase activity at values severalfold higher than required.


View larger version (63K):
[in this window]
[in a new window]
 
Fig. 6.   SDS-PAGE analysis of the expression and purification of recombinant MAT-II protein from E. coli. A, expression of MAT-II recombinant protein. Coomassie Blue-stained SDS-PAGE gel. Lane 1, molecular weight markers; lane 2, E. coli lysate prior to beta -D-thiogalactoside induction; lanes 3-5, soluble fractions of E. coli lysate 30 min, 1 h, and 3 h after induction; lane 6, insoluble fraction of E. coli lysate prior to beta -D-thiogalactoside induction; lanes 7-9, insoluble fractions of E. coli lysate 30 min, 1 h, and 3 h after induction. The arrow shows the expression product. B, purification from inclusion bodies. Lane 1, molecular weight markers; lane 2, E. coli whole cell lysate; lane 3, inclusion body fraction, washed, solubilized in urea, and post-dialyzed.


View larger version (32K):
[in this window]
[in a new window]
 
Fig. 7.   Kinetic analysis of recombinant L. infantum MAT activity. A, concentration-dependent MAT activity at different ATP concentrations and four L-methionine levels. B, concentration-dependent MAT activity at different L-methionine concentrations and four ATP levels. Kinetic constants are provided in the text (K', kcat, and n). C, effect of some potential inhibitors on MAT activity. Each point is the mean of three separate trials.


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 8.   Kinetic analysis of recombinant L. infantum tripolyphosphatase activity. A, concentration-dependent tripolyphosphatase activity at different PPPi concentrations, and the effect of increasing levels of AdoMet. Kinetic constants are provided in the text (K', and kcat). B, effect of some potential activators on tripolyphosphatase activity. Each point is the mean of three separate trials.

The molecular weight of recombinant MAT-II was determined by gel filtration on a Sephacryl S-300 column (75 × 1.5 cm, flowing at 10 ml/h). L. infantum promastigotes were suspended in 50 mM Tris-HCl, pH 8.0, 10 mM DTT, and 10 mM MgSO4, cell suspension was treated as described (33), and the enzymatic extract was loaded onto the Sephacryl S-300 column equilibrated in the same buffer. Recombinant L. infantum MAT-II was prepared as described under "Experimental Procedures." After the fractions collected were separated on SDS-PAGE, the proteins were transferred to a nylon membrane (Sigma) and immunoblotted against the MAT-II antibody. Most of the native protein appeared as a dimer with a molecular mass of 96 kDa, whereas a small monomer fraction with a molecular mass of 49 kDa was also detected. Assays were conducted for MAT activity (33), although only the dimeric fractions were observed to be active.

Effects of Substrate, Products, and Products Analogues on Recombinant L. infantum MAT and Tripolyphosphatase Activity-- The effect of L-amino acid analogues, products, and products analogues on both MAT and tripolyphosphatase activities were assessed. The L-methionine analogues, cycloleucine, L-ethionine, seleno-DL-ethionine, and seleno-L-methionine, showed no appreciable inhibitory effect on MAT activity at any of the concentrations studied (Fig. 7C). However, AdoMet, the natural product of MAT, and other nucleotide analogues such as AdoHcy and S-adenosyl-L-ethionine were found to inhibit the enzyme to a certain extent. AdoMet was the most effective of these compounds reducing MAT activity more than 50% at 1 mM, under standard assay conditions. A Dixon analysis of this compound, at L-methionine concentrations of 0.5-5.0 mM, resulted in a noncompetitive inhibitory pattern with a Ki value of 4 mM. By contrast, in a similar analysis with ATP concentrations of 0.5 to 5.0 mM, a competitive inhibitory effect was observed with a Ki value for the nucleobase of 0.8 mM (data not shown). The presence of the AdoMet S-methyl substituent seems to be an absolutely prerequisite to AdoMet inhibition. AdoMet analogues lacking this methyl moiety such as S-adenosyl-L-cysteine and AdoHcy had little effect on MAT activity. Moreover, replacing the AdoMet methyl group with an ethyl moiety, S-adenosyl-L-ethionine, significantly reduced the inhibitory effect of this analogue. The MAT reaction involves the full dephosphorylation of ATP yielding tripolyphosphate (PPPi) as an intermediate, followed by the release of pyrophosphate (PPi) and orthophosphate (Pi). All these by-products of MAT activity were assayed as potential feedback inhibitors of the enzyme. PPPi was found to be a competitive inhibitor with respect to ATP and L-methionine, with Ki values determined using 0.25 and 0.2 mM Dixon plots, respectively. PPi, one of the final by-products of MAT activity, effectively reduced AdoMet synthesis, with estimated Ki values of 0.3 and 0.35 mM for ATP and L-methionine, respectively. Pi had no inhibitory effect on MAT activity, however. Tripolyphosphatase activity was assessed in the presence of AdoMet and nucleotide analogues (Fig. 8B). Like AdoMet, S-adenosyl-L-ethionine increased tripolyphosphatase activity more than 3-fold at a concentration of 50 µM, and, as in the case of MAT activity, the presence of S-methyl derivative seems to be absolutely requisite to this effect, because neither S-AdoHcy nor S-adenosyl-L-cysteine were found to stimulate enzyme activity.

Analysis of Upstream and Downstream MAT2 Sequences-- A series of luciferase reporter constructs were derived from the pGEM-luc vector (Promega) to analyze the upstream sequences required for expression of a foreign gene in Leishmania. Three different fragments from the region upstream of the MAT2 gene were inserted upstream of the luciferase gene (luc) (Fig. 9). One feature that these fragments have in common is the presence of polypyrimidine tracts upstream of the splice acceptor site. 415-, 355-, and 136-bp fragments were cloned into the pGEM-luc vector, giving rise to p415/luc, p355/luc, and p136/luc constructs used to directly test the effect of polypyrimidine tracts on luciferase expression.


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 9.   Luciferase activity assays in transiently transfected promastigotes. A, plasmid construction used in L. infantum transfections. B, luciferase activity values adjusted to the results of beta -galactosidase assays. Values for pX63NEO-luc transfected cells were set to 100%. Results are shown as mean ± S.D. from five independent experiments.

Parasites were simultaneously transfected with each construction. pGEM-luc vector was used as the negative control. pX63NEO-luc was constructed and used as the positive control by cloning the luciferase gene (derived from pGEM-luc plasmid) into XbaI-NdeI sites in the pX63NEO-beta gal plasmid (kindly provided by Dr. S. M. Beverley, University of Washington, St. Louis, MO). This cleavage released the beta -galactosidase gene making possible its change by the luciferase gene. All the transient transfections included the pX63NEO-beta gal to control experimental variability. The simultaneous presence of plasmids containing reporter luciferase and beta -galactosidase did not interfere with respective enzymatic activities (data not shown).

Parasites transiently transfected with p415/luc, which contains several polypyrimidine tracts, exhibited high levels of luciferase activity, about 40-fold above pGEM-luc activity and 200-fold above the background level. Similar results were obtained when p355/luc and p136/luc were transfected. Therefore, deletions at upstream sequences and polypyrimidine tracts did not affect luciferase activity. To study the role of IR on MAT-II expression, the 4-kb IR was cloned on the p415/luc plasmid, downstream of the luciferase gene. This new construction was called p415/luc/IR. As shown in Fig. 9, parasites transiently transfected with this construction yielded levels of luciferase activity similar to the levels obtained with p415/luc. When the 415-bp fragment was removed, the new construct (called pluc/IR) reduced the activity of transfected parasites to pGEM-luc levels.

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The existence of multiple MAT genes and isozymes in different species is well established. Previous kinetic studies (15) reported two isoforms of the enzyme in T. brucei. The sequence described in this report conserved homologies with S. cerevisiae (60%), Mus musculus (59%), Homo sapiens (59%), Rattus novergicus (58%), P. falciparum (53%), and E. coli (52%) MAT-II (encoded by the MAT2 gene). Sequence homology analysis showed similarities with S. cerevisiae (59%), R. novergicus (57%), H. sapiens (56%), and E. coli (52%) MAT-I/III (encoded by the MAT1 gene). MAT1 and MAT2 sequences described so far have shown high homology, and the BLAST algorithm sequence analysis indicated a higher degree of conserved homology with MAT-II. The reason for the existence of two MAT isozymes is still obscure. Only AdoMet generated by the reaction catalyzed by the metK enzyme would be used to repress the methionine biosynthetic enzyme (36). Because none of the E. coli strains showed size differences in the metK region, it is tempting to speculate that metX arose from a duplication of the metK locus (38). The occurrence of duplicated genes encoding proteins is frequent in Leishmania sp. (38-42). In our study we found two identical copies for the gene that encodes MAT-II. We were not able to determine whether these copies in the L. infantum genome meet cellular needs for AdoMet, i.e. needs that are accommodated for in other source cell MAT-I/III and MAT-II isoforms.

These two copies, arranged in a head-to-tail tandem, are separated by a 4-kb IR. There is no evidence of introns. Most tandemly arranged genes in Trypanosomatids are transcribed into large polycistronic precursor RNAs, which are subsequently processed into monocistronic mRNAs by trans-splicing, in turned followed by addition of a 39-nucleotide spliced leader to the 5'-ends and a poly(A)-tail to the 3'-ends (32). This "cut and paste" mechanism is interrelated, whereby the poly(A) addition is governed by the location of the splice acceptor site on the downstream gene (32). Because no poly(A) signals have been described in Trypanosomatids, the explanation generally accepted for this phenomenon is that the distance between splice acceptor site and the polyadenylation site is conserved (43). The 3'-UTR of L. infantum MAT2 transcript was not analyzed in detail in this study, because no difference in luciferase activity was observed between L. infantum promastigotes transfected with plasmids containing or lacking IR sequences. The minimal vector for transient gene expression in Leishmania consists of a circular plasmid containing a signal for trans-splicing followed by a reporter gene (36). Because polyadenylation and trans-splicing are coupled, a second trans-splicing signal should exist downstream of the reporter gene, a signal which, in our case, seems to be provided by the vector sequence itself. In addition to the suitable distance between the spliced leader acceptor site and the polyadenylation site, the presence of several polypyrimidine-rich motifs is also crucial, because only AG dinucleotides located downstream of a polypyrimidine tract are used as splice acceptor sites. The presence of a 2-kb conserved region upstream of each MAT2 gene, containing both the polypyrimidine tracts and the splice acceptor site, not only suggests the duplication of the ORF but also the surrounding regions, and is indicative of similar control elements for transcription of these two MAT2 genes.

Because the sequences located upstream of the coding regions in both copies of the MAT2 gene are exactly the same, it is impossible for us to ascertain, by 5' mapping analysis, whether both ORFs are able to originate mature mRNAs. It has been shown here that expression of the firefly luciferase gene transfected in L. infantum is dependent on the presence of Leishmania 5'-DNA sequences. These DNA sequences can be provided by truncated 415-, 355-, or 136-bp fragments from the same region that contains the AG trans-splicing acceptor site. All these fragments gave rise to high levels of the luciferase activity. We have shown that a polypyrimidine tract and an AG site located upstream of the luc gene start codon were sufficient to yield luciferase activity without the presence of a promoter region.

The 42-kDa polypeptide predicted on the grounds of theoretical ORF for MAT-II is considerably smaller than 49-kDa estimated by SDS-PAGE in this study. Such discrepancies have been reported for MAT isozymes from different species (3). Anomalously slow migration in SDS-PAGE has been attributed to excess charge density, or more specifically to an unusually high acidic amino acids content. Although the entire MAT-II peptide has a net charge of -7, because many of the basic residues are located in the carboxyl-terminal portion, the first 210 amino acids have a net charge of -19.

L. infantum recombinant MAT-II shows significant sigmoidal kinetic behavior for both L-methionine and ATP. Positive cooperativity for L-methionine was found using Lineweaver-Burk plots but was observed to disappear in the presence of saturating concentrations of ATP (5 mM). Nevertheless, sigmoidal behavior was not ruled out for ATP in the presence of saturating concentration of the L-amino acid. The K' values calculated for L-methionine and ATP correspond to a low affinity enzyme, resembling the dimeric form (MAT-III) of hepatic MAT-I/III isoforms. The tripolyphosphatase activity observed in recombinant L. infantum MAT-II has a sigmoidal behavior and is extremely sensitive to the presence of AdoMet in the incubation medium. The presence of AdoMet in the assay buffer has a paradoxical effect on both MAT and tripolyphosphatase activity. MAT-II is negatively regulated by its product AdoMet in the micromolar range in most of mammalians sources, as well as in S. cerevisiae and E. coli, whereas the simultaneous presence of AdoMet enhances tripolyphosphatase activity several times. The Ki for AdoMet inhibition of Leishmania MAT-II is very high in comparison with its host counterparts and T. brucei. The estimated Ki of 1.5 mM suggests that, unlike the mammalian enzyme, Leishmania MAT activity is weakly regulated by its product. In addition, Northern blot analysis shows that MAT2 is only synthesized by promastigotes in a low range. These characteristics may explain the anomalous accumulation of intracellular AdoMet and dcAdoMet after treatment with DFMO in Trypanosomatids. Other substrate and product analogues showed a weak inhibitory effect on recombinant MAT activity. The final products of dephosphorylation, PPi and Pi, inhibit MAT-II more efficiently than AdoMet. AdoMet analogues, such as AdoHcy, S-adenosylcysteine, or S-adenosylethionine, moreover, only proved to have an inhibitory effect at the millimolar level.

All these results suggest poor post-translational MAT-II regulation in Leishmania parasites. Further experiments will be necessary to assess the MAT2 gene regulation, either at the transcriptional or post-transcriptional level.

    ACKNOWLEDGEMENTS

We thank J. M. Requena and his group for their help with molecular techniques and providing EMBL3 and lambda -gt11, leishmanial libraries, and the LEM-75 L. infantum strain. We also thank M. Pajares for her help in the refolding experiments and S. M. Beverly for the pX63NEO-beta gal vector.

    FOOTNOTES

* This work was supported by Comisión Interministerial de Ciencia y Tecnología (grants PM98/0036 and PB96/0159) and Junta de Castilla y León (grant LE05/01).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) AF031902.

§ To whom correspondence may be addressed: Dpt. Farmacología y Toxicología, Facultad de Veterinaria, Universidad de León, Campus de Vegazana s/n 24071 León, Spain. Tel.: 34-987-291-590; Fax: 34-987-291-252; E-mail: dftrrt@isidoro.unileon.es.

Published, JBC Papers in Press, November 6, 2001, DOI 10.1074/jbc.M105512200

    ABBREVIATIONS

The abbreviations used are: MAT, methionine adenosyltransferase; AdoMet, S-adenosylmethionine; dcAdoMet, decarboxylated S-adenosylmethionine; AdoHcy, S-adenosylhomocysteine; PPPi, tripolyphosphate; Pi, orthophosphate; PPi, pyrophosphate; DFMO, alpha -DL-difluoromethylornithine; RT, reverse transcriptase; ORF, open reading frame; UTR, untranslated region; IR, intergenic region; PBS, phosphate-buffered saline; DTT, dithiothreitol.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Cantoni, G. L. (1953) J. Biol. Chem. 204, 403-416[Free Full Text]
2. Tabor, C. W., and Tabor, H. (1984) Adv. Enzymol. Relat. Areas Mol. Biol. 56, 251-282[Medline] [Order article via Infotrieve]
3. Kotb, M., and Geller, A. M. (1993) Pharmacol. Ther. 59, 125-143[CrossRef][Medline] [Order article via Infotrieve]
4. Chiang, P. K., and Cantoni, G. L. (1977) J. Biol. Chem. 252, 4506-4513[Free Full Text]
5. Chiang, P. K., Gordon, R. K., Tal, J., Zeng, G. C., Doctor, B. P., Pardhasaradhi, K., and McCann, P. P. (1996) FASEB J. 10, 471-480[Abstract]
6. Finkelstein, J. D., Kyle, W. E., Martin, J. L., and Pick, A. M. (1975) Biochem. Biophys. Res. Commun. 66, 81-87[CrossRef][Medline] [Order article via Infotrieve]
7. Mato, J. M., Alvarez, L., Ortiz, P., and Pajares, M. A. (1997) Pharmacol. Ther. 73, 265-280[CrossRef][Medline] [Order article via Infotrieve]
8. Tabor, C. W., and Tabor, H. (1976) Annu. Rev. Biochem. 45, 285-306[CrossRef][Medline] [Order article via Infotrieve]
9. Tabor, C. W., and Tabor, H. (1984) Annu. Rev. Biochem. 53, 749-790[CrossRef][Medline] [Order article via Infotrieve]
10. Pajares, M. A., Corrales, F., Duran, C., Mato, J. M., and Alvarez, L. (1992) FEBS Lett. 309, 1-4[CrossRef][Medline] [Order article via Infotrieve]
11. De La Rosa, J., Ostrowski, J., Hryniewicz, M. M., Kredich, N. M., Kotb, M., LeGros, H. L., Jr., Valentine, H., and Geller, A. M. (1995) J. Biol. Chem. 270, 21860-21868[Abstract/Free Full Text]
12. Horikawa, S., Sasuga, J., Shimizu, K., Ozasa, H., and Tsukada, K. (1990) J. Biol. Chem. 265, 13683-13686[Abstract/Free Full Text]
13. Corrales, F., Cabrero, C., Pajares, M. A., Ortiz, P., Martin-Duce, A., and Mato, J. M. (1990) Hepatology 11, 216-222[Medline] [Order article via Infotrieve]
14. LeGros, H. L., Jr., Halim, A. P., Geller, A. M., and Kotb, M. (2000) J. Biol. Chem. 275, 2359-2366[Abstract/Free Full Text]
15. Yarlett, N., Garofalo, J., Goldberg, B., Ciminelli, M. A., Ruggiero, U., Sufrin, J. R., and Bacchi, C. J. (1993) Biochim. Biophys. Acta 1181, 68-76[Medline] [Order article via Infotrieve]
16. Bacchi, C. J., and Yarlett, N. (1993) Acta Trop. 54, 225-236[CrossRef][Medline] [Order article via Infotrieve]
17. Yarlett, N., and Bacchi, C. J. (1988) Mol. Biochem. Parasitol. 27, 1-10[CrossRef][Medline] [Order article via Infotrieve]
18. Sakata, S. F., Shelly, L. L., Ruppert, S., Schutz, G., and Chou, J. Y. (1993) J. Biol. Chem. 268, 13978-13986[Abstract/Free Full Text]
19. Horikawa, S., Ishikawa, M., Ozasa, H., and Tsukada, K. (1989) Eur. J. Biochem. 184, 497-501[Medline] [Order article via Infotrieve]
20. Horikawa, S., and Tsukada, K. (1991) Biochem. Int. 25, 81-90[Medline] [Order article via Infotrieve]
21. Thomas, D., and Surdin-Kerjan, Y. (1987) J. Biol. Chem. 262, 16704-16709[Abstract/Free Full Text]
22. Thomas, D., Rothstein, R., Rosenberg, N., and Surdin-Kerjan, Y. (1988) Mol. Cell. Biol. 8, 5132-5139[Abstract/Free Full Text]
23. Markham, G. D., DeParasis, J., and Gatmaitan, J. (1984) J. Biol. Chem. 259, 14505-14507[Abstract/Free Full Text]
24. Sanger, F., Nicklen, S., and Coulson, A. R. (1977) Proc. Natl. Acad. Sci. U. S. A. 74, 5463-5467[Abstract/Free Full Text]
25. Soto, M., Requena, J. M., García, M., Gómez, L. C., Navarrete, I., and Alonso, C. (1993) J. Biol. Chem. 268, 21835-21843[Abstract/Free Full Text]
26. Sambrook, J., Fristch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual , 2nd Ed. , Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
27. Southern, E. M. (1975) J. Mol. Biol. 98, 503-517[CrossRef][Medline] [Order article via Infotrieve]
28. Lopez-Vara, M. C., Gasset, M., and Pajares, M. A. (2000) Protein Expr. Purif. 19, 219-226[CrossRef][Medline] [Order article via Infotrieve]
29. Alvarez, L., Mingorance, J., Pajares, M. A., and Mato, J. M. (1994) Biochem. J. 301, 557-561
30. Bradford, M. M. (1976) Anal. Biochem. 72, 248-254[CrossRef][Medline] [Order article via Infotrieve]
31. LeBowitz, J. H. (1994) Methods Cell Biol. 45, 65-78[Medline] [Order article via Infotrieve]
32. LeBowitz, J. H., Coburn, C. M., and Beverley, S. M. (1991) Gene 103, 119-123[CrossRef][Medline] [Order article vi